Please use this identifier to cite or link to this item: http://hdl.handle.net/11054/169
Title: Evidence behind the WHO guidelines: what is the most appropriate anti-fungal treatment for acute cryptococcal meningitis in children with HIV?
Authors: Chimalizeni, Yamikani
Tickell, David
Connell, Tom
Issue Date: 2010
Publisher: Oxford University Press
Place of publication: Oxford
Publication Title: Journal of Tropical Pediatrics
Volume: 56
Issue: 1
Start Page: 4
End Page: 12
Abstract: The World Health Organization has produced guidelines for the management of common illnesses in hospitals with limited resources. This series reviews the scientific evidence behind WHO’s recommendations. The WHO guidelines and more reviews are available at: http://www.ichrc.org. The WHO Pocketbook of Hospital Care for Children [1] recommends treating children with cryptococcal meningitis with intravenous amphotericin B (0.5–1.5 mg kg−1 day−1) for 14 days followed by oral fluconazole (3–6 mg kg−1 day−1) for 8 weeks. Following the management of an acute episode, current recommendations advise ongoing prophylaxis with fluconazole. This review addresses the question: what is the most appropriate anti-fungal treatment for acute cryptococcal meningitis in children with HIV?
URI: http://hdl.handle.net/11054/169
Resource Link: http://tropej.oxfordjournals.org/content/56/1/4.extract
ISSN: 0142-6338
Internal ID Number: 00153
Health Subject: INFANTS
CLINICAL GUIDELINES
ANTI-FUNGAL
HIV
MENINGITIS
CRYPTOCCAL MENINGITIS
Type: Journal Article
Article
Appears in Collections:Research Output

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.